Written by Dr. Daniel Chong. Last reviewed 2026-08-05. 10 min read
The question people ask, and the one they should
The question is almost always "how much is Mounjaro". The more useful question is "what am I actually buying", because the medication is roughly half of what makes this work and it is the only half most clinics quote.
This page sets out the whole arithmetic. We publish our prices anyway, so there is nothing here we would rather you did not know.
The part everyone quotes
Across published Malaysian sources, semaglutide runs roughly RM800 to RM1,800 per pen and tirzepatide roughly RM1,088 to RM3,000 a month. Both figures move with dose.
Two things about that number are routinely left out.
It rises. Most patients start at the lowest dose and climb over several months. The opening month is the cheapest month you will have, and quoting it as the price is technically true and practically misleading.
It is not a programme. It is a box. What happens around the box decides the outcome.
The whole picture
| Component | Why it exists | What happens without it |
|---|---|---|
| Doctor assessment | Establishes whether a GLP-1 is appropriate, and which | People take medication they should not, or the wrong one |
| Baseline bloods | Screens for what needs monitoring during rapid loss | Problems are found late or not at all |
| Body composition | Separates fat loss from lean loss | Muscle loss is invisible until it is done |
| Dietitian care | Keeps protein adequate while appetite is suppressed | The commonest cause of avoidable muscle loss |
| Dose titration | Manages tolerance and rate of loss | Nausea, dropout, or loss fast enough to cost lean tissue |
| The medication | Reduces appetite | Nothing happens |
| Maintenance plan | Decides whether the result holds | Weight returns, and the spend was for a temporary effect |
Six of those seven are not the drug.
For the tirzepatide specifics, including dose titration and the off-label position, see our Mounjaro guide.
Why the cheap route is expensive
You can obtain a GLP-1 more cheaply than a programme costs. Sellers exist online, and some clinics will supply with minimal assessment.
Consider what you are buying in that case. Appetite suppression, with nobody establishing whether you should be on it, nobody managing the rate of loss, nobody measuring what the loss is made of, and nobody planning the exit.
If a quarter to a third of what you lose is lean tissue, your resting metabolic rate falls, regain becomes easier, and you have paid for a result that is harder to keep. That is not a cheaper version of the same thing. It is a different thing.
Counterfeit GLP-1 pens have been reported across the region. Cold chain integrity on an unregulated purchase cannot be verified. We mention it because people do buy this way and deserve to know the risk rather than be lectured about it.
Why we do not discount a course
We price sessions, not packages, and a course costs the sum of its parts.
Discounting a longer commitment sounds generous and creates a problem: it puts financial pressure on a patient to continue treatment that may no longer be clinically appropriate. Inducements of that kind are restricted in Malaysian healthcare advertising, and the restriction exists for a reason we agree with.
If a GLP-1 stops being right for you, we want that decision to be clinical rather than financial.
What we tell people who cannot afford it
That it is a legitimate constraint and worth saying out loud.
A supervised GLP-1 programme is a significant ongoing cost, and for some people the honest recommendation is dietitian-led work without the medication, which is considerably cheaper and produces real results in a proportion of patients. For others, medication is genuinely the thing that unlocks progress after years of trying.
Which of those applies to you is a clinical question, and we would rather answer it accurately than sell the more expensive option to everybody.
What to ask before you pay anyone
Does this quote include the medication, or is it in addition?
What happens to the price as my dose increases?
Is body composition measured, and how often?
Is a dietitian involved, and is that included?
What does the maintenance phase cost?
Five questions. A clinic running a proper programme answers all five without hesitating.
Frequently asked questions
The medication alone runs roughly RM800 to RM1,800 per pen for semaglutide and RM1,088 to RM3,000 a month for tirzepatide across published Malaysian sources, rising as the dose increases. A supervised programme adds assessment, blood work, body composition tracking and dietitian care. Our programme pricing is published on our pricing page so the total is visible before you commit.
Because you start low. Most patients begin at the smallest dose and titrate upward over the first months to manage nausea and tolerance. The dose you settle on is the one to budget for, not the one you start with. Any quote that does not mention this is quoting the easy number.
In cash terms, yes. In outcome terms, frequently not. Without protein management and resistance training a substantial share of what you lose can be lean tissue, which lowers metabolic rate and makes regain easier. Paying less for a worse result is not a saving, though we understand why it looks like one.
We do not price a course below the sum of its sessions. Discounting a medical programme to secure a longer commitment creates pressure to continue treatment that may no longer be appropriate, and inducements of that kind are restricted in Malaysian healthcare advertising for good reason.
RM50 covers a full assessment with a doctor and a tailored plan. It is charged whether or not you proceed, because you are paying for medical time and judgement rather than a sales appointment. If a GLP-1 is not appropriate for you, that is what you will be told.
Semaglutide is generally less expensive than tirzepatide, and oral semaglutide less again, with correspondingly smaller average weight loss in trials. Which is appropriate depends on your clinical picture rather than your budget alone, though budget is a legitimate part of the conversation and we will have it openly.
This article is general educational information and is not medical advice, a diagnosis, or an offer of treatment. GLP-1 receptor agonists are prescription medicines. In Malaysia, semaglutide (Ozempic) and tirzepatide (Mounjaro) are registered with the National Pharmaceutical Regulatory Agency for type 2 diabetes; use for weight management alone is off-label and requires individual assessment by a registered medical practitioner. Wegovy is the semaglutide brand indicated for chronic weight management. Do not start, stop or alter any prescribed medication without speaking to the doctor who prescribed it. Suitability and outcomes vary between individuals and no result can be guaranteed.